Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : Clown-Free Zone... sorry, no clowns allowed -- Ignore unavailable to you. Want to Upgrade?

To: patron_anejo_por_favor who wrote (84635)	3/23/2001 11:33:00 AM
From: sammaster	Respond to of 436258

im taking a look at imnx also... unforunately if market turns down again it may take imnx with it since it is still near 99 lows.... it has great cash, excellent current drugs and good pipeline... enbrel going to get indication for psoriatic arthritis...gm-csf, methotrexate, and other anti-tumor agent current items with large cash hoarde to fund new drug development...

To: patron_anejo_por_favor who wrote (84635)	12/17/2001 2:25:21 PM
From: s.pecunius	Read Replies (1) \| Respond to of 436258

<<Bought some IMNX for a hold. They halted an efficacy trial on ENBREL (their main product) for Congestive Heart Failure, and the stock got cut by 40%. Nonetheless, they have strong sales and earnings growth for the remaining indications and it looks like the selling is overdone. This is the first biotech I've actually BOUGHT in a LOOOONG time.>> Great call! My best buy and hold this year! Your post called my attention to it. Thank you!! I hope you've hold them, too. stockcharts.com[w,a]daclyimy[d20010323,20011217][pc50!c200!c38!c100][vc60][iLa12,26,9!Lb14!Lm12!Lh14,3!Li14,3!Lf!Lc20]